AIRLINK 79.65 Increased By ▲ 0.24 (0.3%)
BOP 5.33 No Change ▼ 0.00 (0%)
CNERGY 4.35 Decreased By ▼ -0.03 (-0.68%)
DFML 34.40 Increased By ▲ 1.21 (3.65%)
DGKC 76.60 Decreased By ▼ -0.27 (-0.35%)
FCCL 20.36 Decreased By ▼ -0.17 (-0.83%)
FFBL 31.44 Increased By ▲ 0.04 (0.13%)
FFL 9.81 Decreased By ▼ -0.04 (-0.41%)
GGL 10.20 Decreased By ▼ -0.05 (-0.49%)
HBL 116.89 Decreased By ▼ -1.04 (-0.88%)
HUBC 134.15 Increased By ▲ 0.05 (0.04%)
HUMNL 6.95 Decreased By ▼ -0.05 (-0.71%)
KEL 4.58 Decreased By ▼ -0.09 (-1.93%)
KOSM 4.64 Decreased By ▼ -0.10 (-2.11%)
MLCF 37.19 Decreased By ▼ -0.25 (-0.67%)
OGDC 136.52 Decreased By ▼ -0.18 (-0.13%)
PAEL 23.20 Increased By ▲ 0.05 (0.22%)
PIAA 27.10 Increased By ▲ 0.55 (2.07%)
PIBTL 6.91 Decreased By ▼ -0.09 (-1.29%)
PPL 113.62 Decreased By ▼ -0.13 (-0.11%)
PRL 27.36 Decreased By ▼ -0.16 (-0.58%)
PTC 14.80 Increased By ▲ 0.05 (0.34%)
SEARL 57.24 Increased By ▲ 0.04 (0.07%)
SNGP 66.76 Decreased By ▼ -0.74 (-1.1%)
SSGC 11.05 Decreased By ▼ -0.04 (-0.36%)
TELE 9.28 Increased By ▲ 0.05 (0.54%)
TPLP 11.69 Increased By ▲ 0.13 (1.12%)
TRG 72.29 Increased By ▲ 0.19 (0.26%)
UNITY 25.27 Increased By ▲ 0.45 (1.81%)
WTL 1.40 No Change ▼ 0.00 (0%)
BR100 7,526 Increased By 0.1 (0%)
BR30 24,603 Decreased By -46.3 (-0.19%)
KSE100 71,919 Decreased By -52.2 (-0.07%)
KSE30 23,735 Decreased By -13.8 (-0.06%)
Markets

European stocks end lower on virus, policy jitters

  • German consumer morale darkens: GfK
  • Travel stocks fall on virus woes
  • Swedish Orphan Biovitrum tops STOXX 600
Published August 26, 2021

European shares ended lower on Thursday after data showed faltering German consumer morale amid rising COVID-19 cases, while investors fretted over US monetary policy ahead of the Jackson Hole symposium.

The pan-European STOXX 600 index fell 0.3%, with mining and travel & leisure stocks leading losses.

The STOXX 600 had briefly deepened its losses towards the close, tracking a fall in US stocks after sentiment was rattled by a blast in Kabul.

Anticipation of the US Federal Reserve's annual Jackson Hole summit on Friday kept investors on their toes, with chair Jerome Powell's speech likely to offer hints on the central bank's plans to taper its massive stimulus programme.

"We think that those expecting clear communication about the shape and timing of the tapering of asset purchases may be disappointed," said Paolo Zanghieri, senior economist at Generali Investments. "The recent data remain strong, but momentum is receding and inflation fears have not surged."

Blast outside Kabul airport kills at least 13, including children: Taliban official

A survey showed the mood among German consumers darkened heading into September as accelerating inflation and rising COVID-19 cases made them more hesitant to buy.

Business morale in the euro zone's largest economy fell for the second month running in August, data on Wednesday showed.

"Risks are tilted to the downside over the near term," analysts at BCA Research said. "While global COVID-19 cases appear to be rolling over and (China's) Ningbo-Zhoushan port has reopened, which are both positive for supply chains, COVID-19 cases are still climbing in Germany."

European travel company Tui, airlines Wizz Air , Lufthansa and British Airways-owner IAG fell by between 0.9% and 3.8%.

Wizz Air was the worst performer on the STOXX 600, dropping 3.8%.

Germany's blue-chip DAX dropped 0.4%, marking its lowest closing level in a week, while the UK's FTSE 100 and France's CAC 40 declined by 0.4% and 0.2%, respectively.

Deutsche Bank's asset management arm DWS Group fell 13.7% on a report US authorities were investigating DWS over sustainability claims. Deutsche Bank's shares dropped 1.5%.

France's Vivendi rose 2.6% after its unit Universal Music Group said it expects further revenue growth this year and it aims to pay out dividends once it lists in Amsterdam.

French conglomerate Bouygues gained 1.1% as it raised its full-year earnings outlook.

Swedish Orphan Biovitrum was the best performer on the STOXX 600, rising 8.8% after Bloomberg reported that private equity firm Advent International is considering a bid for the pharmaceutical maker.

Comments

Comments are closed.